Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial
Jemima Beissbarth, Nicole Wilson, Beth Arrowsmith, Michael J Binks, Victor Oguoma, Lawrence Kelly, A. Llewellyn, Edward Kim Mulholland, Mathuram Santosham, Peter Stanley Morris, Heidi Carol Smith-Vaughan, Allen C. Cheng, Amanda J Leach
Dive into the research topics of 'Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial'. Together they form a unique fingerprint.